Clinical Trial Update: Chemoresistance and Involvement of the NOTCH Pathway in Patients With Lung Adenocarcinoma

View source ↗

Summary

This clinical trial update discusses chemoresistance and involvement of the NOTCH signaling pathway in patients with lung adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Lung Adenocarcinoma | Status: UNKNOWN